LiverReady: A Comprehensive Digital Platform for Remotely Monitoring MASH/MASLD Symptoms & Personalizing Adherence Support to Prevent Dropout in Clinical Trials
Time: 11:50 am
day: Conf Day 1 Track 2 AM
Details:
- Describe remotely monitored digital biomarkers and their emerging contribution to tracking patient symptoms and treatment efficacy in clinical trials
- Discuss diagnostic biomarkers and relevant endpoints for MASH/MASLD that have potential to be remotely monitored
- Review LiverReady, a comprehensive digital platform for remotely monitoring symptoms in MASH/MASLD, determining risk of non-adherence, and providing personalized interventions to enhance adherence and retention in clinical trials
